scholarly article | Q13442814 |
P356 | DOI | 10.1159/000112945 |
P8608 | Fatcat ID | release_qbrudnrzpba5jlbbvnvoscmtii |
P698 | PubMed publication ID | 18176087 |
P2093 | author name string | Morito Monden | |
Makoto Yamasaki | |||
Shuji Takiguchi | |||
Yuichiro Doki | |||
Hiroshi Miyata | |||
Yoshiyuki Fujiwara | |||
Junya Fujita | |||
Ryohei Kawabata | |||
Yasuo Tsukahara | |||
P2860 | cites work | Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer | Q46683166 |
Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002). | Q46685954 | ||
Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer | Q46828997 | ||
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer. | Q54127938 | ||
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer | Q33488159 | ||
Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer | Q34366342 | ||
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group | Q34572233 | ||
Paclitaxel (taxol) | Q34723890 | ||
Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG). | Q35134370 | ||
Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro | Q36136024 | ||
Taxol stabilizes microtubules in mouse fibroblast cells | Q36360499 | ||
Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma | Q36381830 | ||
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer | Q36612612 | ||
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer | Q36673543 | ||
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions | Q43754196 | ||
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. | Q46658481 | ||
P433 | issue | 3-4 | |
P921 | main subject | paclitaxel | Q423762 |
P304 | page(s) | 219-225 | |
P577 | publication date | 2007-01-01 | |
P1433 | published in | Oncology | Q2016300 |
P1476 | title | Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer | |
P478 | volume | 72 |
Q42915841 | Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer |
Q37534441 | Paclitaxel chemotherapy for the treatment of gastric cancer |
Q44441494 | Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer |
Search more.